Global Opioids Market Insights, Forecast to 2025

2 Global Opioids Quarterly Market Size Analysis

• 2.1 Opioids Business Impact Assessment - COVID-19
  • 2.1.1 Global Opioids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Opioids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Opioids Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Opioids Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Opioids Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Opioids Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Opioids Market
• 3.5 Key Manufacturers Opioids Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Opioids Segments, By Type

• 4.1 Introduction
  • 1.4.1 Immediate-Release/Short-Acting Opioid
  • 1.4.2 Extended-Release/Long-Acting Opioid
• 4.2 By Type, Global Opioids Market Size, 2019-2021
  • 4.2.1 By Type, Global Opioids Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Opioids Price, 2020-2021

5 Impact of Covid-19 on Opioids Segments, By Application

• 5.1 Overview
  • 5.5.1 Pain Relief
  • 5.5.2 Anesthesia
  • 5.5.3 Cough Suppression
  • 5.5.4 Diarrhea Suppression
  • 5.5.5 Deaddiction
• 5.2 By Application, Global Opioids Market Size, 2019-2021
  • 5.2.1 By Application, Global Opioids Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Opioids Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Purdue Pharma L.P.
  • 7.1.1 Purdue Pharma L.P. Business Overview
  • 7.1.2 Purdue Pharma L.P. Opioids Quarterly Production and Revenue, 2020
  • 7.1.3 Purdue Pharma L.P. Opioids Product Introduction
  • 7.1.4 Purdue Pharma L.P. Response to COVID-19 and Related Developments
• 7.2 West-Ward Pharmaceuticals Corporation
  • 7.2.1 West-Ward Pharmaceuticals Corporation Business Overview
  • 7.2.2 West-Ward Pharmaceuticals Corporation Opioids Quarterly Production and Revenue, 2020
  • 7.2.3 West-Ward Pharmaceuticals Corporation Opioids Product Introduction
  • 7.2.4 West-Ward Pharmaceuticals Corporation Response to COVID-19 and Related Developments
• 7.3 Allergan
  • 7.3.1 Allergan Business Overview
  • 7.3.2 Allergan Opioids Quarterly Production and Revenue, 2020
  • 7.3.3 Allergan Opioids Product Introduction
  • 7.3.4 Allergan Response to COVID-19 and Related Developments
• 7.4 Pfizer, Inc.
  • 7.4.1 Pfizer, Inc. Business Overview
  • 7.4.2 Pfizer, Inc. Opioids Quarterly Production and Revenue, 2020
  • 7.4.3 Pfizer, Inc. Opioids Product Introduction
  • 7.4.4 Pfizer, Inc. Response to COVID-19 and Related Developments
• 7.5 Janssen Pharmaceuticals, Inc.
  • 7.5.1 Janssen Pharmaceuticals, Inc. Business Overview
  • 7.5.2 Janssen Pharmaceuticals, Inc. Opioids Quarterly Production and Revenue, 2020
  • 7.5.3 Janssen Pharmaceuticals, Inc. Opioids Product Introduction
  • 7.5.4 Janssen Pharmaceuticals, Inc. Response to COVID-19 and Related Developments
• 7.6 Egalet Corporation
  • 7.6.1 Egalet Corporation Business Overview
  • 7.6.2 Egalet Corporation Opioids Quarterly Production and Revenue, 2020
  • 7.6.3 Egalet Corporation Opioids Product Introduction
  • 7.6.4 Egalet Corporation Response to COVID-19 and Related Developments
• 7.7 Sun Pharmaceutical Industries Limited.
  • 7.7.1 Sun Pharmaceutical Industries Limited. Business Overview
  • 7.7.2 Sun Pharmaceutical Industries Limited. Opioids Quarterly Production and Revenue, 2020
  • 7.7.3 Sun Pharmaceutical Industries Limited. Opioids Product Introduction
  • 7.7.4 Sun Pharmaceutical Industries Limited. Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Opioids Supply Chain Analysis
  • 8.1.1 Opioids Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Opioids Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Opioids Distribution Channels
  • 8.2.2 Covid-19 Impact on Opioids Distribution Channels
  • 8.2.3 Opioids Distributors
• 8.3 Opioids Customers

9 Key Findings

10 Appendix

• 10.1 About Us